Colgate-Palmolive Company (CL)
Official siteCONSUMER DEFENSIVE • HOUSEHOLD & PERSONAL PRODUCTS • NYSE
Market Cap: $79.23B
Last updated: Nov 17, 2026 at 11:05 AM ET
Colgate-Palmolive Company (CL) Financials: Revenue, Profit and Cash Flow
Colgate-Palmolive Company reported revenue of $20.38B for the fiscal year ended Dec 31, 2025, up 1.4% from the year before. That year, net income was $2.26B with a net margin of 11.1%, operating cash flow was $4.20B and free cash flow was $3.63B. The quarter ended Sep 30, 2026 had revenue of $5.37B and net income of $779.00M.
Revenue and Margins
The operating margin was 16.2% in the fiscal year ended Dec 2025. Over the 9 years to Dec 2025, revenue grew from $15.20B, a compound annual rate of 3.3%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $20.38B | +1.4% | 60.1% | 16.2% | 11.1% |
| Dec 2024 | $20.10B | +3.3% | 60.5% | 21.2% | 15.2% |
| Dec 2023 | $19.46B | +8.3% | 58.2% | 20.5% | 12.6% |
| Dec 2022 | $17.97B | +3.1% | 57.0% | 16.1% | 10.9% |
| Dec 2021 | $17.42B | +5.8% | 59.6% | 19.1% | 13.4% |
| Dec 2020 | $16.47B | +5.0% | 60.8% | 23.6% | 17.4% |
| Dec 2019 | $15.69B | +1.0% | 59.4% | 22.6% | 16.1% |
| Dec 2018 | $15.54B | +0.6% | 59.4% | 23.8% | 16.5% |
| Dec 2017 | $15.45B | +1.7% | 60.0% | 24.0% | 14.1% |
| Dec 2016 | $15.20B | N/A | 60.0% | 26.0% | 17.0% |
Income Statement
In the fiscal year ended Dec 2025, net income fell 25.9% from the year before. In the quarter ended Sep 2026, net income rose 1.7% from the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $20.38B | $20.10B | $19.46B | $17.97B | $17.42B | $16.47B | $15.69B | $15.54B | $15.45B | $15.20B |
| Cost of revenue | $8.13B | $7.94B | $8.13B | $7.72B | $7.05B | $6.45B | $6.37B | $6.31B | $6.17B | $6.07B |
| Gross profit | $12.25B | $12.16B | $11.33B | $10.25B | $10.38B | $10.02B | $9.32B | $9.23B | $9.28B | $9.12B |
| Operating income | $3.31B | $4.27B | $3.98B | $2.89B | $3.33B | $3.88B | $3.55B | $3.69B | $3.71B | $3.96B |
| Net income | $2.26B | $3.05B | $2.46B | $1.97B | $2.34B | $2.86B | $2.53B | $2.56B | $2.17B | $2.59B |
| EBITDA | $3.88B | $4.79B | $4.19B | $3.36B | $3.82B | $4.35B | $3.96B | $4.12B | $4.18B | $4.28B |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.37B | $5.36B | $5.32B | $5.23B | $5.13B | $5.11B | $4.91B | $4.95B | $5.03B | $5.06B | $5.07B | $4.95B |
| Gross profit | $3.23B | $3.30B | $3.23B | $3.15B | $3.05B | $3.07B | $2.99B | $2.98B | $3.07B | $3.07B | $3.04B | $2.95B |
| Operating income | $1.09B | $1.02B | $964.00M | $91.00M | $1.06B | $1.08B | $1.08B | $1.06B | $1.06B | $1.09B | $1.05B | $1.07B |
| Net income | $779.00M | $719.00M | $681.00M | -$4.00M | $766.00M | $773.00M | $726.00M | $777.00M | $776.00M | $767.00M | $729.00M | $760.00M |
Balance Sheet
As of Dec 2025, total debt of $7.99B exceeded cash and equivalents by $6.70B.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $16.33B | $16.05B | $16.39B | $15.73B | $15.04B | $15.92B | $15.03B | $12.16B | $12.68B | $12.12B |
| Current assets | $5.71B | $5.32B | $5.28B | $5.11B | $4.40B | $4.34B | $4.18B | $3.79B | $4.64B | $4.34B |
| Cash and equivalents | $1.29B | $1.10B | $966.00M | $775.00M | $832.00M | $888.00M | $883.00M | $726.00M | $1.53B | $1.31B |
| Total liabilities | $15.96B | $15.50B | $15.44B | $14.93B | $14.07B | $14.82B | $14.48B | $11.96B | $12.43B | $12.11B |
| Short-term debt | $1.12B | $660.00M | $330.00M | $25.00M | $51.00M | $267.00M | $514.00M | $12.00M | $11.00M | $13.00M |
| Long-term debt | $6.87B | $7.29B | $8.22B | $8.74B | $7.19B | $7.33B | $7.33B | $6.35B | $6.57B | $6.52B |
| Shareholder equity | $54.00M | $212.00M | $609.00M | $401.00M | $609.00M | $743.00M | $117.00M | -$102.00M | -$60.00M | -$243.00M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $16.74B | $16.79B | $16.61B | $16.33B | $17.51B | $17.47B | $16.65B | $16.05B | $16.77B | $16.48B | $16.57B | $16.39B |
| Total liabilities | $16.10B | $16.22B | $16.12B | $15.96B | $16.27B | $16.42B | $15.91B | $15.50B | $15.94B | $16.00B | $15.95B | $15.44B |
| Cash and equivalents | $1.53B | $1.37B | $1.33B | $1.29B | $1.28B | $1.22B | $1.11B | $1.10B | $1.23B | $1.11B | $1.08B | $966.00M |
| Shareholder equity | $288.00M | $236.00M | $145.00M | $365.00M | $856.00M | $702.00M | $363.00M | $544.00M | $435.00M | $123.00M | $230.00M | $957.00M |
Cash Flow
In the fiscal year ended Dec 2025, free cash flow was 86.4% of operating cash flow. Dividends and share repurchases together came to 83.5% of it.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $4.20B | $4.11B | $3.75B | $2.56B | $3.33B | $3.72B | $3.13B | $3.06B | $3.05B | $3.14B |
| Capital expenditures | $564.00M | $561.00M | $705.00M | $696.00M | $567.00M | $410.00M | $335.00M | $436.00M | $553.00M | $593.00M |
| Free cash flow | $3.63B | $3.55B | $3.04B | $1.86B | $2.76B | $3.31B | $2.80B | $2.62B | $2.50B | $2.55B |
| Dividends paid | $1.82B | $1.79B | $1.75B | $1.69B | $1.68B | $1.75B | $1.61B | $1.59B | $1.53B | $1.51B |
| Share repurchases | $1.21B | $1.74B | $1.13B | $1.31B | $1.32B | $1.48B | $1.20B | $1.24B | $1.40B | $1.33B |
| Investing cash flow | -$817.00M | -$534.00M | -$742.00M | -$1.60B | -$592.00M | -$779.00M | -$2.10B | -$1.17B | -$471.00M | -$499.00M |
| Financing cash flow | -$3.26B | -$3.39B | -$2.79B | -$952.00M | -$2.77B | -$2.92B | -$870.00M | -$2.68B | -$2.45B | -$2.23B |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $1.17B | $995.00M | $747.00M | $1.45B | $1.26B | $884.00M | $600.00M | $1.27B | $1.17B | $990.00M | $681.00M | $1.14B |
| Capital expenditures | $134.00M | $128.00M | $138.00M | $177.00M | $155.00M | $108.00M | $124.00M | $184.00M | $134.00M | $117.00M | $126.00M | $197.00M |
| Free cash flow | $1.04B | $867.00M | $609.00M | $1.28B | $1.11B | $776.00M | $476.00M | $1.08B | $1.03B | $873.00M | $555.00M | $939.00M |
Frequently Asked Questions About CL
What is Colgate-Palmolive Company's annual revenue?
Colgate-Palmolive Company reported revenue of $20.38B for the fiscal year ended Dec 31, 2025.
How fast is Colgate-Palmolive Company's revenue growing?
Revenue was up 1.4% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 4.3%.
Is Colgate-Palmolive Company profitable?
Yes. Colgate-Palmolive Company reported net income of $2.26B for the fiscal year ended Dec 31, 2025, with a net margin of 11.1%.
How much free cash flow does CL generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of $4.20B minus capital expenditures of $564.00M produced free cash flow of $3.63B.
How much debt does Colgate-Palmolive Company have?
The balance sheet dated Dec 31, 2025 reported long-term debt of $6.87B, short-term debt of $1.12B and cash and equivalents of $1.29B.
CL pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors